Biden wants to cover weight loss meds. RFK Jr. would rather we just eat better.
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr. may not be such a fan.
Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning.
Biden admin. proposes coverage for weight-loss drugs by Medicare, Medicaid
Share on Facebook Share on Twitter Under a new rule the Biden administration proposed on Tuesday, millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or
Biden proposes weight loss drug coverage requirements for Medicare and Medicaid
Weight loss drugs like Wegovy, Zepbound and Ozempic would be covered by Medicare and Medicaid under a Biden administration proposal.
Biden proposes government-funded weight-loss jabs threatening row with RFK Jr
A row is brewing between the White House and Robert F Kennedy Jr after the Biden administration proposed making millions of Americans eligible for government-funded weight-loss drugs.
Biden Proposes Expanded Medicare, Medicaid Coverage of Obesity Drugs
Current rules for the Medicare and Medicaid government health insurance programs cover the use of drugs such as Mounjaro, Ozempic and Wegovy for certain conditions like diabetes, but not for obesity as a condition on its own.
Biden’s plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars
The plan would need to be supported by the incoming Trump administration, which has vowed to cut costs across the federal government.
Biden administration calls for Medicare and Medicaid to cover drugs used for weight loss
The Biden administration called for Medicare and Medicaid to cover popular drugs that help people lose weight but are not affordable for many Americans who might benefit from them. NBC News' Stephanie Gosk reports.
Biden Proposal to Cover Obesity Drugs Sets Up Quandary for Trump
The Biden administration is proposing a rule that would require the US government to cover obesity drugs for millions of Americans, teeing up a financial and political challenge for President-elect Donald Trump as he prepares to take office.
Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President-elect Donald Trump.
Biden wants Medicare, Medicaid to cover pricey weight loss drugs such as Wegovy
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Weight-loss drug Zepbound might help manage heart failure
Zepbound, a drug used to help patients lose weight and manage diabetes, may also help those with heart failure, a new trial ...
How to preserve muscle mass on weight-loss drugs like Wegovy
There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...
Wegovy costs $1,349 in the US vs. $92 in the UK. Why are weight loss drugs so pricey?
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
STAT1d
Medicare moves to expand coverage for weight-loss drugs Wegovy, Zepbound
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...
health.wusf.usf.edu21h
Weight loss drugs could soon be covered by Medicare and Medicaid
The Biden administration is looking to extend Medicare and Medicaid coverage to include obesity drugs like Wegovy and Zepbound. Weight loss drugs are now excluded from mandatory coverage.
healthday12h
Zepbound Slashes Diabetes Risk in Obese Users
The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical ...
Investor's Business Daily on MSN1d
Amgen Crashes After Weight-Loss Drug Only Meets Eli Lilly's Zepbound
Amgen stock crashed Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's ...